Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Retinitis Pigmentosa Stem Cell Protocol Goes into Clinical Trials

Posted by anna@stemsave.com on Nov 5, 2015 2:03:00 PM

Dr. Henry Klassen of UC Irvine has initiated an FDA approved stem cell based clinical trial for the treatment of Retinitis Pigmentosa (RP) through the regeneration of damaged retinal tissue. RP is caused by the slow decay of photoreceptors in the retina, which provide vital chemical communication to the brain. The disease is thought to derive from mutations in genes responsible for rods and cones, which ultimately lead to blindness. There is no current treatment for RP.

Read More

Topics: stemsaveblog, Retinitis Pigmentosa, Eyes, clinical trial, retinal blindness, mesenchymal stem cells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all